RAYNAUD PHENOMENON IN 3 PATIENTS WITH ACQUIRED IMMUNE-DEFICIENCY SYNDROME-RELATED KAPOSI-SARCOMA TREATED WITH BLEOMYCIN

Authors
VONGUNTEN CF ROTH EL VANROENN JH
Citation
Cf. Vongunten et al., RAYNAUD PHENOMENON IN 3 PATIENTS WITH ACQUIRED IMMUNE-DEFICIENCY SYNDROME-RELATED KAPOSI-SARCOMA TREATED WITH BLEOMYCIN, Cancer, 72(6), 1993, pp. 2004-2006
Citations number
13
Categorie Soggetti
Oncology
Journal title
Cancer → ACNP
ISSN journal
0008543X
Volume
72
Issue
6
Year of publication
1993
Pages
2004 - 2006
Database
ISI
SICI code
0008-543X(1993)72:6<2004:RPI3PW>2.0.ZU;2-A
Abstract
The authors report three cases of Raynaud phenomenon that developed du ring doxorubicin, bleomycin, and vincristine (ABV) therapy for acquire d immune deficiency syndrome (AIDS)-related Kaposi sarcoma. Although R aynaud phenomenon is well documented as a side effect of bleomycin, vi nblastine, and cisplatin chemotherapy for germ cell neoplasms, it has not been widely documented in patients with AIDS.